Research groups All groups >>

As a group we have experience on epidemiology and clinical research on the topics of hypertension, acute coronary syndrome, heart failure and atrial fibrillation.

We participate in ongoing programs like CHANCE-Heart Failure, a clinical trial assessing the value of biomarker CA125 in the management of patients with heart failure, supported by a CAIBER grant and promoted by another group (HCUV-SERCAR, PI Dr. Sanchis) of the same scientific program. As a clinical group we have possibility of recruiting patients and also have serum stored in a serum bank at the Department.

Contributions to the HERACLES Programme:

Biomarker & other prognostic factors in ACS, stroke & CHF patients

1. Predictive functions & biomarkers for ACS without ST elevation
2. Predictive function &biomarkers for patients with CHF of recent onset

Cohort participant & patient follow-ups. New therapeutic approaches. Statistical analyses: function fitting & performance.

Latest publications

• Roldán Rabadán I, Anguita Sánchez M, Marín F, Quesada MA, Camacho Siles J, Peinado R, Bertomeu V, Cequier Fillat A, Badimon L, Muñiz J Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry. Rev Esp Cardiol (Engl Ed) 2016; 69: 54-60

  View abstract

• Anguita Sánchez M, Bertomeu Martínez V, Cequier Fillat A Heart Failure, Nonvalvular Atrial Fibrillation and Anticoagulation Control With Vitamin K Antagonists. Rev Esp Cardiol (Engl Ed) 2016; 69: 75-6

  View abstract

• Cordero A, Galve E, Bertomeu-Martínez V, Bueno H, Fácila L, Alegria E, Cequier A, Ruiz E, González-Juanatey JR Trends in Risk Factors and Treatments in Patients With Stable Ischemic Heart Disease Seen at Cardiology Clinics Between 2006 and 2014. Rev Esp Cardiol (Engl Ed) 2016; 69: 401-7

  View abstract

• Sayols-Baixeras S, Subirana I, Lluís-Ganella C, Civeira F, Roquer J, Do AN, Absher D, Cenarro A, Muñoz D, Soriano-Tarraga C, Jiménez-Conde J, Ordovas JM, Sentí M, Aslibekyan S, Marrugat J, Arnett DK, Elosua R Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study. Hum. Mol. Genet. 2016; 25: 4556-4565

  View abstract

• Bertomeu-González V, Anguita M, Moreno-Arribas J, Cequier A, Muñiz J, Castillo-Castillo J, Sanchis J, Roldán I, Marín F, Bertomeu-Martínez V Quality of Anticoagulation With Vitamin K Antagonists. Clin Cardiol 2015; 38: 357-64

  View abstract

• Cabrera de León A, Oliva García JG, Marcelino Rodríguez I, Almeida González D, Alemán Sánchez JJ, Brito Díaz B, Domínguez Coello S, Bertomeu Martínez V, Aguirre Jaime A, Rodríguez Pérez Mdel C C-peptide as a risk factor of coronary artery disease in the general population. Diab Vasc Dis Res 2015; 12: 199-207

  View abstract

• Roldán Rabadán I, Anguita Sánchez M, Marín F, Quesada MA, Camacho Siles J, Peinado R, Bertomeu V, Cequier Fillat A, Badimon L, Muñiz J Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry. Rev Esp Cardiol (Engl Ed) 2015; :

  View abstract

• Anguita Sánchez M, Bertomeu Martínez V, Cequier Fillat A Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors. Rev Esp Cardiol (Engl Ed) 2015; 68: 761-8

  View abstract

• Sanchis J, Abellán L, García-Blas S, Mainar L, Mollar A, Valero E, Consuegra-Sanchez L, Roqué M, Bertomeu-González V, Chorro FJ, Núñez E, Núñez J Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain. Eur Heart J Acute Cardiovasc Care 2015; :

  View abstract

• Anguita M, Marín F, Roldán I, Cequier A, Bertomeu V, Muñiz J Satisfaction with medical care in patients with atrial fibrillation treated with vitamin K antagonists versus new oral anticoagulants. Rev Esp Cardiol (Engl Ed) 2015; 68: 537-9

  View abstract

All publications